---
document_datetime: 2025-12-02 06:18:05
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/filgrastim-ratiopharm.html
document_name: filgrastim-ratiopharm.html
version: success
processing_time: 0.0986975
conversion_datetime: 2025-12-28 05:17:49.950244
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Filgrastim ratiopharm

[RSS](/en/individual-human-medicine.xml/65496)

##### Withdrawn

This medicine's authorisation has been withdrawn

filgrastim Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 15 September 2009 the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Filgrastim ratiopharm (filgrastim) for the treatment of neutropenia. Filgrastim ratiopharm was a biological medicinal product and a biosimilar of the product Neupogen. The marketing authorisation holder (MAH) for Filgrastim ratiopharm was ratiopharm GmbH.

The European Commission was notified by a letter dated 24 March 2011 of the MAH's decision to voluntarily withdraw the marketing authorisation for Filgrastim ratiopharm. Filgrastim ratiopharm was not marketed in any EU country.

On 20 April 2011 the European Commission issued a decision to withdraw the marketing authorisation for Filgrastim ratiopharm.

Pursuant to this decision the European Public Assessment Report for Filgrastim ratiopharm is updated to reflect that the marketing authorisation is no longer valid.

Filgrastim ratiopharm : EPAR - Summary for the public

English (EN) (235 KB - PDF)

**First published:** 30/09/2008

**Last updated:** 20/07/2011

[View](/en/documents/overview/filgrastim-ratiopharm-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-978)

български (BG) (423.57 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/bg/documents/overview/filgrastim-ratiopharm-epar-summary-public_bg.pdf)

español (ES) (235.42 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/es/documents/overview/filgrastim-ratiopharm-epar-summary-public_es.pdf)

čeština (CS) (393.48 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/cs/documents/overview/filgrastim-ratiopharm-epar-summary-public_cs.pdf)

dansk (DA) (253.08 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/da/documents/overview/filgrastim-ratiopharm-epar-summary-public_da.pdf)

Deutsch (DE) (256.89 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/de/documents/overview/filgrastim-ratiopharm-epar-summary-public_de.pdf)

eesti keel (ET) (238.72 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/et/documents/overview/filgrastim-ratiopharm-epar-summary-public_et.pdf)

ελληνικά (EL) (427.28 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/el/documents/overview/filgrastim-ratiopharm-epar-summary-public_el.pdf)

français (FR) (235.77 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/fr/documents/overview/filgrastim-ratiopharm-epar-summary-public_fr.pdf)

italiano (IT) (239.47 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/it/documents/overview/filgrastim-ratiopharm-epar-summary-public_it.pdf)

latviešu valoda (LV) (373.5 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/lv/documents/overview/filgrastim-ratiopharm-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (353.76 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/lt/documents/overview/filgrastim-ratiopharm-epar-summary-public_lt.pdf)

magyar (HU) (362.05 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/hu/documents/overview/filgrastim-ratiopharm-epar-summary-public_hu.pdf)

Malti (MT) (375.01 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/mt/documents/overview/filgrastim-ratiopharm-epar-summary-public_mt.pdf)

Nederlands (NL) (235.41 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/nl/documents/overview/filgrastim-ratiopharm-epar-summary-public_nl.pdf)

polski (PL) (380.38 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/pl/documents/overview/filgrastim-ratiopharm-epar-summary-public_pl.pdf)

português (PT) (235.38 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/pt/documents/overview/filgrastim-ratiopharm-epar-summary-public_pt.pdf)

română (RO) (364.52 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/ro/documents/overview/filgrastim-ratiopharm-epar-summary-public_ro.pdf)

slovenčina (SK) (372.18 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/sk/documents/overview/filgrastim-ratiopharm-epar-summary-public_sk.pdf)

slovenščina (SL) (363.79 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/sl/documents/overview/filgrastim-ratiopharm-epar-summary-public_sl.pdf)

Suomi (FI) (238.79 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/fi/documents/overview/filgrastim-ratiopharm-epar-summary-public_fi.pdf)

svenska (SV) (239.29 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/sv/documents/overview/filgrastim-ratiopharm-epar-summary-public_sv.pdf)

## Product information

Filgrastim ratiopharm : EPAR - Product Information

English (EN) (755.28 KB - PDF)

**First published:** 30/09/2008

**Last updated:** 20/07/2011

[View](/en/documents/product-information/filgrastim-ratiopharm-epar-product-information_en.pdf)

[Other languages (23)](#file-language-dropdown-27)

български (BG) (2.35 MB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/bg/documents/product-information/filgrastim-ratiopharm-epar-product-information_bg.pdf)

español (ES) (872.15 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/es/documents/product-information/filgrastim-ratiopharm-epar-product-information_es.pdf)

čeština (CS) (1.61 MB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/cs/documents/product-information/filgrastim-ratiopharm-epar-product-information_cs.pdf)

dansk (DA) (797.42 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/da/documents/product-information/filgrastim-ratiopharm-epar-product-information_da.pdf)

Deutsch (DE) (796.49 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/de/documents/product-information/filgrastim-ratiopharm-epar-product-information_de.pdf)

eesti keel (ET) (793.7 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/et/documents/product-information/filgrastim-ratiopharm-epar-product-information_et.pdf)

ελληνικά (EL) (2.41 MB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/el/documents/product-information/filgrastim-ratiopharm-epar-product-information_el.pdf)

français (FR) (831.5 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/fr/documents/product-information/filgrastim-ratiopharm-epar-product-information_fr.pdf)

íslenska (IS) (802.87 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/is/documents/product-information/filgrastim-ratiopharm-epar-product-information_is.pdf)

italiano (IT) (824.36 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/it/documents/product-information/filgrastim-ratiopharm-epar-product-information_it.pdf)

latviešu valoda (LV) (1.77 MB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/lv/documents/product-information/filgrastim-ratiopharm-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.04 MB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/lt/documents/product-information/filgrastim-ratiopharm-epar-product-information_lt.pdf)

magyar (HU) (1.6 MB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/hu/documents/product-information/filgrastim-ratiopharm-epar-product-information_hu.pdf)

Malti (MT) (1.67 MB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/mt/documents/product-information/filgrastim-ratiopharm-epar-product-information_mt.pdf)

Nederlands (NL) (797.94 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/nl/documents/product-information/filgrastim-ratiopharm-epar-product-information_nl.pdf)

norsk (NO) (841.64 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/no/documents/product-information/filgrastim-ratiopharm-epar-product-information_no.pdf)

polski (PL) (1.76 MB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/pl/documents/product-information/filgrastim-ratiopharm-epar-product-information_pl.pdf)

português (PT) (812.3 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/pt/documents/product-information/filgrastim-ratiopharm-epar-product-information_pt.pdf)

română (RO) (1.04 MB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/ro/documents/product-information/filgrastim-ratiopharm-epar-product-information_ro.pdf)

slovenčina (SK) (1.62 MB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/sk/documents/product-information/filgrastim-ratiopharm-epar-product-information_sk.pdf)

slovenščina (SL) (1.55 MB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/sl/documents/product-information/filgrastim-ratiopharm-epar-product-information_sl.pdf)

Suomi (FI) (856.13 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/fi/documents/product-information/filgrastim-ratiopharm-epar-product-information_fi.pdf)

svenska (SV) (810.55 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/sv/documents/product-information/filgrastim-ratiopharm-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0001/G 20/04/2011

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Filgrastim ratiopharm : EPAR - All Authorised presentations

English (EN) (216.57 KB - PDF)

**First published:** 30/09/2008

**Last updated:** 20/07/2011

[View](/en/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-297)

български (BG) (299.98 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/bg/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_bg.pdf)

español (ES) (216.56 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/es/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_es.pdf)

čeština (CS) (293.64 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/cs/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (216.64 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/da/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (216.57 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/de/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (216.64 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/et/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (295.17 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/el/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_el.pdf)

français (FR) (216.65 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/fr/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (216.59 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/it/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (294.46 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/lv/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (284.13 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/lt/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (292.04 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/hu/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (293.22 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/mt/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (216.57 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/nl/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_nl.pdf)

polski (PL) (294.55 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/pl/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_pl.pdf)

português (PT) (216.58 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/pt/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_pt.pdf)

română (RO) (281.13 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/ro/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (292.35 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/sk/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (225.78 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/sl/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (216.48 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/fi/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (216.62 KB - PDF)

**First published:**

30/09/2008

**Last updated:**

20/07/2011

[View](/sv/documents/all-authorised-presentations/filgrastim-ratiopharm-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Filgrastim ratiopharm Active substance filgrastim International non-proprietary name (INN) or common name filgrastim Therapeutic area (MeSH)

- Hematopoietic Stem Cell Transplantation
- Cancer

Anatomical therapeutic chemical (ATC) code L03AA02

### Pharmacotherapeutic group

Immunostimulants

### Therapeutic indication

Filgrastim ratiopharm is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia. The safety and efficacy of filgrastim are similar in adults and children receiving cytotoxic chemotherapy.

Filgrastim ratiopharm is indicated for the mobilisation of peripheral blood progenitor cells (PBPC).

In patients, children or adults, with severe congenital, cyclic, or idiopathic neutropenia with an absolute neutrophil count (ANC) of 0.5 x 109/l, and a history of severe or recurrent infections, long term administration of Filgrastim ratiopharm is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.

Filgrastim ratiopharm is indicated for the treatment of persistent neutropenia (ANC less than or equal to 1.0 x 109/l) in patients with advanced HIV infection, in order to reduce the risk of bacterial infections when other options to manage neutropenia are inappropriate.

## Authorisation details

EMA product number EMEA/H/C/000824

Biosimilar

This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the 'reference medicine'. For more information, see [Biosimilar medicines](/node/68323) .

Marketing authorisation holder

Ratiopharm GmbH

ratiopharm GmbH

Marketing authorisation issued 15/09/2008 Withdrawal of marketing authorisation 20/04/2011 Revision 1

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Filgrastim ratiopharm : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (245.04 KB - PDF)

**First published:** 07/03/2011

**Last updated:** 20/07/2011

[View](/en/documents/procedural-steps-after/filgrastim-ratiopharm-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Filgrastim ratiopharm : EPAR - Public assessment report

English (EN) (1018.45 KB - PDF)

**First published:** 30/09/2008

**Last updated:** 20/07/2011

[View](/en/documents/assessment-report/filgrastim-ratiopharm-epar-public-assessment-report_en.pdf)

Committee for medicinal products for human use summary of positive opinion for Filgrastim ratiopharm

Reference Number: EMEA/CHMP/67399/2008

English (EN) (34.55 KB - PDF)

**First published:** 21/02/2008

**Last updated:** 21/02/2008

[View](/en/documents/smop-initial/committee-medicinal-products-human-use-summary-positive-opinion-filgrastim-ratiopharm_en.pdf)

**This page was last updated on** 20/07/2011

## Share this page

[Back to top](#main-content)